- Appendiceal tumor
- Bile duct cancer (Cholangiocarcinoma)
- Esophageal cancer
- Gastric cancer (Stomach cancer)
- Hepatocellular carcinoma
- Liver cancer
- Neuroendocrine tumors
- Pancreatic cancer
- Small bowel cancer
Nevena Damjanov, MD
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Penn Presbyterian
Penn Medicine Provider
About me
- Section Chief Hematology/Oncology, VA Medical Center
- Director of Gastrointestinal Oncology, Abramson Cancer Center, Penn Presbyterian Medical Center
- Professor of Clinical Medicine (Hematology-Oncology)
My education and training
- Medical School: Drexel University College of Medicine
- Residency: Penn State Milton S. Hershey Medical Center
- Fellowship: University Hospitals Cleveland Medical Center
- Fellowship: University of Pennsylvania Health System
Spoken languages
English
English
Reviews
126 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- Hematology, 1996
- Medical Oncology, 1995
- Internal Medicine, 1992
- American Medical Association, National
- American Society of Clinical Oncology, National
- Philadelphia Research and Education Foundation (PREF), Local
- Penn Gastrointestinal Cancer Program
- Penn Liver Cancer Program
- Penn Neuroendocrine Tumor Program
Treatments and conditions
Research
Publications
Uri Amit, James M Metz, John P Plastaras, Rohi Gheewala, Ursina Teitelbaum, Nevena Damjanov, Charles Vollmer, Charles J Schneider, Major Kenneth Lee 4th, Mark O'Hara, Kim Reiss-Binder, Erica L Carpenter, Thomas B Karasic, Andre Konski, E Paul Wileyto, Edgar Ben-Josef A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancer , Cancer, 131(12): 2025
L. Goyal, D. DiToro, F. Facchinetti, E. E. Martin, P. Peng, I. Baiev, R. Iyer, J. Maurer, S. Reyes, K. Zhang, U. Majeed, J. E. Berchuck, C. T. Chen, C. Walmsley, C. Pinto, D. Vasseur, J. D. Gordan, K. Mody, M. Borad, T. Karasic, N. Damjanov, B. P. Danysh, E. Wehrenberg-Klee, A. R. Kambadakone, S. K. Saha, I. D. Hoffman, K. J. Nelson, S. Iyer, X. Qiang, C. Sun, H. Wang, L. Li, M. Javle, B. Lin, W. Harris, A. X. Zhu, J. M. Cleary, K. T. Flaherty, T. Harris, R. T. Shroff, I. Leshchiner, L. Parida, R. K. Kelley, J. Fan, J. R. Stone, N. V. Uboha, H. Hirai, H. Sootome, F. Wu, D. C. Bensen, A. Hollebecque, L. Friboulet, J. K. Lennerz, G. Getz, D. Juric A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma , Annals of Oncology, 36(4): 2024,426-443
Mari Angelica Cayabyab1, Glenda Hoffecker, Lisa Varughese, Victoria Wittner, Jean De Dieu Ndayishimiye, Xingmei Wang, Joseph Bleznuck, Rachel Hatch1, Donna Capozzi, Avni Santani, Hakon Hakonarson, Ryan C. Massa, Nevena Damjanov, Nandi J. Reddy, Randall A. Oyer, Ursina R. Teitelbaum, Sony Tuteja From paper to practice: Implementing preemptive Dihydropyridine dehydrogenase (DPYD) testing & pharmacogenomic (PGx)-guided dosing to reduce serious treatment-related adverse events (TRAEs) in gastrointestinal malignancies , ACCP: 2024
Monica M. Matsumoto, MD, Enrique F. Schisterman, PhD, Michael C. Soulen, MD, Shilpa Reddy, MD, Mike Sheng, MD, Tamim Khaddash, MD, Nevena Damjanov, MD, Emma E. Furth, MD, Stephen J. Hunt, MD PhD, Gregory J. Nadolski, MD MTR, David E. Kaplan, MD MSc, Terence P.F. Gade, MD PhD Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma: The Phase I-II qTACE Trial , Journal of Vascular and Interventional Radiology: 2024
Sony Tuteja, Mari Cayabyab, Glenda Hoffecker, Lisa A. Varughese, Jean De Dieu. Ndayishimiye, Victoria Wittner, Xingmei Wang, Margaret Harr, Avni Santani, Hakon Hakonarson, Ryan Massa, Nevena Damjanov, Nandi Reddy, Randy Oyer, Ursina R. Teitelbaum Implementing DPYD/UGT1A1 testing to prevent treatment related adverse events (TRAE) in patients with gastrointestinal (GI) cancer: results of a pragmatic implementation trial , J Clin Oncol: 2024
Michael C Soulen, Ursina R Teitelbaum, Rosemarie Mick, Jennifer Eads, Jeffrey I Mondschein, Mandeep Dagli, Diana van Houten, Nevena Damjanov, Charles Schneider, Keith Cengel, David C Metz Integrated capecitabine-temozolomide with radioembolization for liver-dominant G2 NETs: long-term outcomes of a single-institution retrospective study , Cardiovasc Intervent Radiol : 2024
Sony Tuteja, Mari Cayabyab, Glenda Hoffecker, Lisa A. Varughese, Jean D. Ndayishimiye, Victoria Wittner, Xingmei Wang, Rachel Hatch, Donna Capozzi, Margaret Harr, Avni Santani, Hakon Hakonarson, Ryan Massa, Nevena Damjanov, Nandi Reddy, Randy Oyer, Ursina R. Teitelbaum Implementing DPYD/UGT1A1 testing to prevent treatment related adverse events (TRAEs) in patients with gastrointestinal (GI) cancer: results of a pragmatic implementation trial , ClinPGx 2024: Knowledge, Implementation & Education: 2024
Jeffrey W. Shevach, MD, Lisa B. Aiello, PhD, RN, AOCNS, Julie A. Lynch, PhD, RN, MBA, Jeffrey Petersen, MD, Lori Hoffman-Hogg, MS, RN, CNS, AOCN, Deborah Hartzfeld, MS, Margaret Lundquist, DNP, MPH, CRNP, Michael J. Kelley, MD, Maren T. Scheuner, MD, MPH, Robert Montgomery, MD Nevena Damjanov, MD Kyle Robinson, MD, Yu-Ning Wong, MD, Darshana Jhala, MD, Ravi B. Parikh, MD, MPH, and Kara N. Maxwell, MD, PhD On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black Veterans , JCO Oncology Practice, 19(8): 2023
Damjanov, N Clinical Edge Journal Scan Commentary: HCC , MDEdge: 2022
Damjanov, N Clinical Edge Journal Scan Commentary: HCC , MDEdge: 2022